Patents by Inventor Andrew David Otte

Andrew David Otte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11000479
    Abstract: The present disclosure relates to naltrexone sustained release microparticle delivery systems for the treatment of diseases ameliorated by naltrexone. The injectable microparticle delivery system includes naltrexone encapsulated in biodegradable microparticles administered in a pharmaceutically acceptable vehicle.
    Type: Grant
    Filed: October 15, 2019
    Date of Patent: May 11, 2021
    Assignees: Chong Kun Dang Pharmaceutical Corp., Purdue Research Foundation
    Inventors: Gwangheum Yoon, Bong Kwan Soh, Andrew David Otte, Kinam Park
  • Publication number: 20200113835
    Abstract: The present disclosure relates to naltrexone sustained release microparticle delivery systems for the treatment of diseases ameliorated by naltrexone. The injectable microparticle delivery system includes naltrexone encapsulated in biodegradable microparticles administered in a pharmaceutically acceptable vehicle.
    Type: Application
    Filed: October 15, 2019
    Publication date: April 16, 2020
    Inventors: Gwangheum Yoon, Bong Kwan Soh, Andrew David Otte, Kinam Park